Business Wire

OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens

26.5.2026 15:15:00 CEST | Business Wire | Press Release

Share

OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures.

OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leading AI providers, including Anthropic, Google, OpenAI, xAI, and DeepSeek, among others. The platform is used by over 8 million global users, including AI-native startups and large enterprises, and its rankings and usage data have become a widely referenced signal of real-world model adoption, performance, and pricing dynamics.

The company will use the new capital to expand its routing, governance, and optimization capabilities as enterprises increasingly deploy AI into production. A 2026 Deloitte study found that 67% of enterprises are already consuming over one billion tokens per month. OpenRouter is seeing a shift toward multi-model strategies, where companies route across models and providers to optimize for cost, latency, and capability, creating operational complexity that requires centralized control.

"Running inference at scale is fundamentally a multi-model problem. The era of picking a single model is over," said Alex Atallah, CEO and co-founder of OpenRouter. "Success now depends on continuously routing across a changing market. Because OpenRouter sits in the flow of production traffic, we can optimize every request for cost, performance, and reliability in real time."

“Every platform shift creates infrastructure gaps: from Cloudflare with the internet and Stripe with digital payments, to Databricks with data and AI. These infrastructure gaps create opportunities for generational businesses to solve real customer needs. OpenRouter is solving the infrastructure gap for inference in the AI era,” said Mo Jomaa, partner at CapitalG.

“As companies shift toward a multi-model paradigm, OpenRouter enables them to seamlessly leverage the right model for every task,” added Jane Alexander, partner at CapitalG. “OpenRouter is uniquely positioned to become the data clearinghouse and unified intelligence layer for AI models.”

As AI usage has exploded worldwide, OpenRouter’s public rankings and usage data have become a widely referenced source of real-world insight into model adoption, performance, and pricing, used by investors, researchers, and media organizations to understand how the AI market is evolving.

About OpenRouter

OpenRouter is the AI model exchange, enabling developers and enterprises to access, route, and optimize across hundreds of AI models through a single API. Founded in 2023, the company sits between agents, applications, and the model ecosystem, standardizing access to leading providers through one unified interface. Organizations can enforce controls like per-request data handling policies, team-level access and routing permissions, spend visibility, and audit-friendly usage reporting. Intelligent routing improves cost and performance while automated failover increases reliability, and multi-provider interoperability reduces lock-in and vendor risk.

Learn more at https://openrouter.ai

About CapitalG

CapitalG, Alphabet's independent growth fund, invests in generational technology companies transforming the world’s largest markets. CapitalG partners with growth stage companies in their transition from startup to scale up through hands-on assistance and connections to advisors at Google, Alphabet and beyond. CapitalG’s portfolio companies include Baseten, Clay, CrowdStrike, Databricks, Duolingo, LangChain, Lovable, OpenRouter, Stripe, and Whatnot, among others. Learn more at https://capitalg.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260526953416/en/

Contacts

Media Contact
Melissa Sobel, melissasobel@capitalg.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Alipay Launches Next-Generation AI Payment Infrastructure, Debuts AI Wallet and Token Pay to Power Agentic Economy26.5.2026 17:20:00 CEST | Press Release

Alipay today introduced its full-stack AI payment solution to partners across industries, ranging from AI companies to traditional retailers, and debuted two new services — the world’s first AI Wallet and Token Pay — to support the agentic economy’s rapid growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526337824/en/ Alipay Unveils Next-generation AI Payment Infrastructure This launch extends Alipay's next-generation AI payment infrastructure, building on its consumer-facing product Alipay AI Pay and its business-facing AI payment processing product. “While the essence of commerce remains unchanged in the age of AI, the emergence of AI agents is reshaping everything. Drawing on 22 years of technological expertise and commercial know-how, Alipay is building a new generation of AI payment services to accelerate the growth of the agentic commerce ecosystem,” said Cyril Han, CEO of Ant Group. AI Wallet: Giving Users Vis

Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 202626.5.2026 17:00:00 CEST | Press Release

Daiichi Sankyo Europe (DSE) is pleased to announce its extensive scientific presence at the European Atherosclerosis Society (EAS) Congress 2026. The presentation of 15 abstracts, comprising both clinical trial analyses and real-world evidence, underscores the company's sustained investment in cardiovascular health and its mission to care for every heartbeat. The 15-abstract showcase provides a comprehensive look at the role of bempedoic acid in lipid management. This includes post-hoc analyses in collaboration with Esperion Therapeutics from the Phase 3 CLEAR Outcomes trial exploring its impact on stroke and venous thromboembolism (VTE) incidence.5,6 There are also real-world findings from the MILOS registry, including a dedicated sub-analysis investigating the effectiveness of bempedoic acid across various background therapies.1,2,3,4 Results reinforce consistent effectiveness and safety profile of bempedoic acid across various EU countries and regardless of patients’ existing treatm

Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 15:00:00 CEST | Press Release

Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in markets traditional channels can't reach. Each operates at the center of how games are discovered, adopted, an

Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press Release

Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar

ViaLase Announces Global Commercial Introduction of the FLIGHT Procedure26.5.2026 14:00:00 CEST | Press Release

ViaLase, Inc., a commercial stage medical technology company pioneering incision-free, laser-based solutions for glaucoma, today announced the successful completion of the first commercial FLIGHT procedures performed at Centre for Sight in London by Sheraz Daya, MD, and Gus Gazzard, MD, and at Breyer, Kaymak & Klabe Augenchirurgie in Düsseldorf, Germany, by Karsten Klabe, MD. The first commercial FLIGHT procedures were performed using the ViaLuxe® Laser System to deliver an incision-free, image-guided femtosecond laser treatment designed to create precise channels through the trabecular meshwork to restore aqueous outflow and reduce intraocular pressure in patients with open-angle glaucoma. “Centre for Sight has always been committed to bringing meaningful innovation to patients through technologies that advance precision, safety, and the overall treatment experience,” said Sheraz Daya, MD, Medical Director and Founder of Centre for Sight. “We are proud to be the first center globally

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye